Patent details

Basic Information

Publication number:

EP3727349

PCT Application Number:

EP2018085593

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP188220537

PCT Publication Number:

WO2019121748

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

NANOPARTICLES FOR USE FOR TREATING A NEURONAL DISORDER

French Title of Invention:

NANOPARTICULES DESTINÉES À ÊTRE UTILISÉES POUR TRAITER UN TROUBLE NEURONAL

German Title of Invention:

NANOPARTIKEL ZUR VERWENDUNG ZUR BEHANDLUNG EINER NEURONALEN STÖRUNG

SPC Number:

Dates

Filing date:

18/12/2018

Grant date:

07/08/2024

EP Publication Date:

28/10/2020

PCT Publication Date:

27/06/2019

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/08/2024

EP B1 Publication Date:

07/08/2024

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

18/12/2024

Expiration date:

18/12/2038

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

31/07/2024

 

 

Name:

Nanobiotix

Address:

60 rue de Wattignies, 75012 Paris, France (FR)

Inventor

1

Name:

MEYRE, Marie-Edith

Address:

France (FR)

2

Name:

POTTIER, Agnès

Address:

France (FR)

3

Name:

LEVY, Laurent

Address:

France (FR)

Priority

Priority Number:

17306826

Priority Date:

19/12/2017

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61K 47/69; A61K 9/51; A61K 33/00; A61P 25/00; A61P 25/16; A61P 25/28; B82Y 5/00;

Publication

European Patent Bulletin

Issue number:

202432

Publication date:

07/08/2024

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages